Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,270 | 980 | 750 | 1,280 | 1,770 |
| Receivables | 180 | 660 | 990 | 1,110 | 1,140 |
| Other current assets | 670 | 770 | 500 | 190 | 1,070 |
| TOTAL | $2,120 | $2,410 | $2,240 | $2,580 | $3,980 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 4,790 |
| Other Non-Current Assets | 460 | 610 | 1,430 | 1,340 | 430 |
| TOTAL | $460 | $610 | $1,430 | $1,340 | $5,220 |
| Total Assets | $2,860 | $3,380 | $4,220 | $4,770 | $5,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 370 | 390 | 530 | 700 | 470 |
| Other current liabilities | 160 | 280 | 620 | 660 | 320 |
| TOTAL | $530 | $680 | $1,150 | $1,370 | $1,170 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 40 | 0 | 0 |
| Other Non-Current Liabilities | 30 | 40 | 0 | 40 | 60 |
| TOTAL | $30 | $40 | $40 | $40 | $60 |
| Total Liabilities | $570 | $720 | $1,200 | $1,410 | $1,240 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 1 | 1 | 1 |
| Retained earnings | -2,470 | -2,260 | -2,220 | -1,850 | -960 |
| Other shareholders' equity | -150 | -240 | -361 | -401 | -451 |
| TOTAL | $2,290 | $2,660 | $3,020 | $3,350 | $3,980 |
| Total Liabilities And Equity | $2,860 | $3,380 | $4,220 | $4,760 | $5,220 |